Asensus Surgical, Inc. Announces Sapporo Medical University Hospital in Japan to Initiate Senhance Robotic Surgery Program
Retrieved on:
Wednesday, September 29, 2021
Data Management, Health, FDA, Medical Devices, Technology, Surgery, Pharmaceutical, Adoption, Goal, ISU, Securities Act of 1933, Regenerative medicine, Deep learning, Health, Disaster, Annual report, Drug Quality and Security Act, Surgical oncology, Private Securities Litigation Reform Act, Security (finance), Sale, U.S. Securities and Exchange Commission, Surgeon, Patient, Surgery, Sapporo, CEO, Program, AIDS, Intelligence, Securities Exchange Act of 1934, Machine learning, Robotics, Movement, Bed, HIV, NYSE, SEC, Dentistry, Medicine, Medical device, Sapporo Medical University Hospital, Asensus Surgical, Inc., SAPPORO MEDICAL UNIVERSITY HOSPITAL, ASENSUS SURGICAL, INC.
Sapporo Medical University Hospital has facilities in 29 clinical divisions and 932 inpatient beds.
Key Points:
- Sapporo Medical University Hospital has facilities in 29 clinical divisions and 932 inpatient beds.
- In 1996, the hospital was certified as an advanced treatment facility capable of providing advanced medical treatment, developing medical technologies, and offering training.
- The hospital also functions as an AIDS treatment core hospital (HIV Hokkaido Regional Hospital), a core disaster medical hospital, the Hokkaido Rehabilitation Support Center, and a regional cancer center.
- This press release includes statements relating to the Senhance Surgical System and Sapporo Medical University Hospital initiating a program with the Senhance System.